Products

Human F13A1(Coagulation Factor XIII A1 Polypeptide) ELISA Kit
One-click to copy product information
ELK1762
Size： Price：
48 T $320.00
96 T $458.00
96 T*5 $1947.00
Manual MSDS Send email to us

Overview

Product name: Human F13A1(Coagulation Factor XIII A1 Polypeptide) ELISA Kit
Reactivity: Human
Alternative Names: F13-A1; FXIIIA1; Protein-glutamine gamma-glutamyltransferase A chain; Transglutaminase A chain; Coagulation factor XIII A chain
Assay Type: Sandwich
Sensitivity: 0.071 ng/mL
Standard: 12 ng/mL
Detection Range: 0.19-12 ng/mL
Sample Type: plasma
Assay Length: 3.5h
Research Area: Signal transduction;Metabolic pathway;Hematology;
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human F13A1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human F13A1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human F13A1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human F13A1 in the samples is then determined by comparing the OD of the samples to the standard curve.

Standard curve

Concentration (ng/mL) OD Corrected OD
12.00 1.946 1.859
6.00 1.528 1.441
3.00 1.194 1.107
1.50 0.806 0.719
0.75 0.559 0.472
0.38 0.324 0.237
0.19 0.258 0.171
0.00 0.087 0.000

Precision

Intra-assay Precision (Precision within an assay)：CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)：CV%<10%

Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.

Recovery

Matrices listed below were spiked with certain level of recombinant F13A1 and the recovery rates were calculated by comparing the measured value to the expected amount of F13A1 in samples.
Matrix Recovery range Average
serum(n=5) 79-97% 88%
EDTA plasma(n=5) 81-97% 89%
Heparin plasma(n=5) 85-97% 91%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of F13A1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix 1:2 1:4 1:8 1:16
serum(n=5) 83-97% 84-99% 95-102% 88-103%
EDTA plasma(n=5) 86-95% 91-106% 87-100% 95-101%
Heparin plasma(n=5) 95-102% 83-97% 88-96% 96-103%